Southern Medical Journal · 2006 · 36 citations · 10 references
MedicineEmergency MedicineNeurologyNeurocritical CareNeurological Critical CareVisual DisordersCortical Visual ImpairmentIntracranial HypertensionVisual ImpairmentBlood PressureCerebral ComplicationsMental Status ChangesMultiorgan Failure ManagementNeurologic DeficitsSystolic Blood PressureToxic EncephalopathyToxic Leukoencephalopathy
Posterior reversible encephalopathy syndrome (PRES), also known as reversible posterior leukoencephalopathy syndrome (RPLS), is most often associated with hypertensive emergencies and is characterized by seizures, mental status changes and visual disturbances. We report a case of a previously healthy young man who developed multiorgan failure and transient cortical blindness following ingestion of a performance-enhancing ephedra-based supplement. Neuroimaging findings confirmed the clinical suspicion of PRES. Radiographic abnormalities and neurologic dysfunction subsequently resolved with correction of his systolic blood pressure. This case emphasizes the need for prompt treatment and consideration of toxic ingestions in patients presenting with hypertension-related end-organ dysfunction.
10
A Reversible Posterior Leukoencephalopathy Syndrome
Judy Hinchey, Claudia Chaves, B A Appignani et al. · New England Journal of Medicine · 1996 · 3.3K citations
Robert A. Hauser · Archives of Neurology · 1988 · 195 citations
The Relative Safety of Ephedra Compared with Other Herbal Products
Stephen Bent, Thomas N. Tiedt, Michelle C. Odden et al. · Annals of Internal Medicine · 2003 · 165 citations
Erythropoietin-associated hypertensive posterior leukoencephalopathy
Norman Delanty, Carl J. Vaughan, Steven J. Frucht et al. · Neurology · 1997 · 121 citations
Medicine, Neurology, Pharmacotherapy +16